Adimab
Adimab is a company focused on developing human monoclonal and bispecific antibodies for oncology, immunomodulation, inflammation, neuroscience, and pain.
All edits by Joshua Elkington
Edits on 29 Mar, 2020
Joshua Elkington
Edits made to:
Table (+1 rows) (+4 cells) (+69 characters)
Table
Find more companies like Adimab
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
